Your browser doesn't support javascript.
loading
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer.
Eser, Pinar Özden; Paranal, Raymond M; Son, Jieun; Ivanova, Elena; Kuang, Yanan; Haikala, Heidi M; To, Ciric; Okoro, Jeffrey J; Dholakia, Kshiti H; Choi, Jihyun; Eum, Yoonji; Ogino, Atsuko; Missios, Pavlos; Ercan, Dalia; Xu, Man; Poitras, Michael J; Wang, Stephen; Ngo, Kenneth; Dills, Michael; Yanagita, Masahiko; Lopez, Timothy; Lin, Mika; Tsai, Jeanelle; Floch, Nicolas; Chambers, Emily S; Heng, Jennifer; Anjum, Rana; Santucci, Alison D; Michael, Kesi; Schuller, Alwin G; Cross, Darren; Smith, Paul D; Oxnard, Geoffrey R; Barbie, David A; Sholl, Lynette M; Bahcall, Magda; Palakurthi, Sangeetha; Gokhale, Prafulla C; Paweletz, Cloud P; Daley, George Q; Jänne, Pasi A.
Afiliación
  • Eser PÖ; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Paranal RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Son J; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215, USA.
  • Ivanova E; Harvard Medical School, Boston, MA 02115, USA.
  • Kuang Y; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Haikala HM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • To C; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Okoro JJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Dholakia KH; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215, USA.
  • Choi J; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Eum Y; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Ogino A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Missios P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Ercan D; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215, USA.
  • Xu M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Poitras MJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Wang S; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215, USA.
  • Ngo K; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Dills M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Yanagita M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Lopez T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Lin M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Tsai J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Floch N; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Chambers ES; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Heng J; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Anjum R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Santucci AD; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215, USA.
  • Michael K; Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA.
  • Schuller AG; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Cross D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Smith PD; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Oxnard GR; Experimental Therapeutics Core, Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Barbie DA; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Sholl LM; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Bahcall M; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Palakurthi S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Gokhale PC; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Paweletz CP; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Daley GQ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Jänne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Sci Transl Med ; 13(609): eabb3738, 2021 Sep.
Article en En | MEDLINE | ID: mdl-34516823
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores ErbB / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores ErbB / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos